Galapagos SAS

Patent Applications and Registrations

Patent applications and USPTO patent grants for Galapagos SAS.The latest application filed is for "pyrimidine derivatives which are antagonists of the vitronectin receptor".

Company Profile

0.5.5

Galapagos SAS -
Galapagos SAS - Romainville FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimidine Derivatives Which Are Antagonists Of The Vitronectin Receptor App 20120115883 - Lefrancois; Jean-Michel ; et al.	2012-05-10
Recombinant cell lines for the stable and high-level production of biologically active Dkk1 protein Grant 8,158,417 - Mollat , et al. April 17, 2	2012-04-17
Pyrimidine Derivatives Which Are Antagonist Of The Vitronectin Receptor App 20110039867 - Lefrancois; Jean-Michel ; et al.	2011-02-17
Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor Grant 7,846,932 - Lefrancois , et al. December 7, 2	2010-12-07
Pyrimidine derivatives which are antagonists of vitronectin receptor Grant 7,825,119 - Lefrancois , et al. November 2, 2	2010-11-02
Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same Grant 7,763,621 - Ruxer , et al. July 27, 2	2010-07-27
Methods For The Use Of Pyrimidine Derivatives Which Are Antagonists Of Vitronectin Receptor App 20100041675 - Lefrancois; Jean-Michel ; et al.	2010-02-18
Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same Grant 7,582,640 - Ruxer , et al. September 1, 2	2009-09-01
Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same App 20090149476 - Ruxer; Jean-Marie ; et al.	2009-06-11
Recombinant Cell Lines for the Stable and High-Level Production of Biologically Active Dkk1 Protein App 20080248526 - Mollat; Patrick ; et al.	2008-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.